Search results
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
Motley Fool via Yahoo Finance· 5 months agoWith AbbVie (NYSE: ABBV) reporting on Nov. 30 that it plans to acquire ImmunoGen, (NASDAQ: IMGN) a...
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The...
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 10 months agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
Better Long-Term Buy: AbbVie or Novo Nordisk?
Motley Fool· 11 months agoPharmaceutical companies Novo Nordisk (NYSE: NVO) and AbbVie (NYSE: ABBV) seem to be headed in separate directions. Denmark-based Novo Nordisk, thanks to...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 7 months agoAbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV recently announced that it has acquired UK-based private biotech, DJS Antibodies...
Better Growth Stock: Abbott vs. AbbVie
Motley Fool via Yahoo Finance· 4 months agoAbbott Laboratories (NYSE: ABT) and AbbVie (NYSE: ABBV) share a common past. About a decade ago, Abbott spun out its pharmaceuticals business into a...
